These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 29602276)

  • 1. Octreotide for congenital and acquired chylothorax in newborns: A systematic review.
    Bellini C; Cabano R; De Angelis LC; Bellini T; Calevo MG; Gandullia P; Ramenghi LA
    J Paediatr Child Health; 2018 Aug; 54(8):840-847. PubMed ID: 29602276
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Octreotide for the treatment of chylothorax in neonates.
    Das A; Shah PS
    Cochrane Database Syst Rev; 2010 Sep; (9):CD006388. PubMed ID: 20824848
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Octreotide as therapeutic option for congenital idiopathic chylothorax: a case series.
    Shah D; Sinn JK
    Acta Paediatr; 2012 Apr; 101(4):e151-5. PubMed ID: 22092874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin or octreotide as treatment options for chylothorax in young children: a systematic review.
    Roehr CC; Jung A; Proquitté H; Blankenstein O; Hammer H; Lakhoo K; Wauer RR
    Intensive Care Med; 2006 May; 32(5):650-7. PubMed ID: 16532329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should Newborns with Refractory Chylothorax Be Tried on Higher Dose of Octreotide?
    Vass G; Evans Fry R; Roehr CC
    Neonatology; 2021; 118(1):122-126. PubMed ID: 33494092
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of somatostatin/octreotide treatment in neonates with congenital chylothorax.
    Yin R; Zhang R; Wang J; Yuan L; Hu L; Jiang S; Chen C; Cao Y
    Medicine (Baltimore); 2017 Jul; 96(29):e7594. PubMed ID: 28723800
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Octreotide--additional conservative therapy for postoperative chylothorax in congenital heart disease.
    Paramés F; Freitas I; Fragata J; Trigo C; Pinto MF
    Rev Port Cardiol; 2009; 28(7-8):799-807. PubMed ID: 19894659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Report of a case of neonatal chylothorax that responded to long-term octreotide treatment, and review of the literature.
    Çakır U; Kahvecioğlu D; Yıldız D; Alan S; Erdeve Ö; Atasay B; Arsan S
    Turk J Pediatr; 2015; 57(2):195-7. PubMed ID: 26690606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of chylothorax with octreotide after congenital heart surgery.
    Tatar T; Kilic D; Ozkan M; Hatipoglu A; Aslamaci S
    Thorac Cardiovasc Surg; 2011 Aug; 59(5):298-301. PubMed ID: 21394709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Octreotide for Acquired Chylothorax in Pediatric Patients Post-Cardiothoracic Surgery for Congenital Heart Disease: A Systematic Review.
    Jenkinson AC; McGuinness J; Prendiville T
    Pediatr Cardiol; 2023 Feb; 44(2):297-305. PubMed ID: 36255468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Congenital chylothorax treated with octreotide.
    Sahin Y; Aydin D
    Indian J Pediatr; 2005 Oct; 72(10):885-8. PubMed ID: 16272667
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Congenital chylothorax in a late preterm infant and successful treatment with octreotide.
    Foo NH; Hwang YS; Lin CC; Tsai WH
    Pediatr Neonatol; 2011 Oct; 52(5):297-301. PubMed ID: 22036228
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Idiopathic congenital chylothorax treated with octreotide.
    Sousa PR; Leitão H; Camacho MC; Nunes JL
    BMJ Case Rep; 2010 May; 2010():. PubMed ID: 22750919
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Octreotide for treatment of chylothorax after repair of congenital diaphragmatic hernia.
    Goyal A; Smith NP; Jesudason EC; Kerr S; Losty PD
    J Pediatr Surg; 2003 Aug; 38(8):E19-20. PubMed ID: 12891519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of congenital chylothorax with octreotide in a hydropic preterm infant.
    Choo YM; Lim CT
    Paediatr Int Child Health; 2013 May; 33(2):116-9. PubMed ID: 23925288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Octreotide in the treatment of congenital chylothorax.
    Rasiah SV; Oei J; Lui K
    J Paediatr Child Health; 2004; 40(9-10):585-8. PubMed ID: 15367160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Octreotide, a somatostatin analogue, in the treatment of chylothorax associated with idiopathic fibrosing mediastinitis.
    Togashi Y; Kim YH; Miyahara R; Irisa K; Sakamori Y; Masago K; Mio T; Date H; Mishima M
    Tohoku J Exp Med; 2010 Sep; 222(1):51-3. PubMed ID: 20814178
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is octreotide treatment useful in patients with congenital chylothorax?
    Horvers M; Mooij CF; Antonius TA
    Neonatology; 2012; 101(3):225-31. PubMed ID: 22076538
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Can octreotide be the first line treatment for chylothorax?
    Leelahanon S; Petlek W; Sontimuang W; Pochanart P; Tepakorn V; Ruangpeg S
    J Med Assoc Thai; 2003 Aug; 86 Suppl 3():S741-5. PubMed ID: 14700175
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of neonatal chylothorax with octreotide.
    Khatami SF; Parvaresh P
    Indian J Pediatr; 2011 Nov; 78(11):1412-4. PubMed ID: 21625833
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.